๐๏ธ Verified NIH Record โข Updated 2026-07-28
Study of DSP-0390 in Patients With Recurrent High-Grade Glioma (NCT05023551)
A Phase 1 Study of DSP-0390 in Patients With Recurrent High-Grade Glioma
๐ต Active, Not Recruiting Early Phase1 ๐ Investigational Drug / Biologic Sponsor: Sumitomo Pharma America, Inc.
๐ฉบ Plain-English Summary (8th-Grade Level)
This is a study of DSP-0390 in patients with recurrent high grade glioma.
Who can join: Review the eligibility criteria below.
Location: University of California at San Francisco โ San Francisco, California
Age range: 18 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (9 Sites)
- University of California at San Francisco โ San Francisco, California
- Dana Farber Cancer Institute โ Boston, Massachusetts
- Washington University School of Medicine โ St Louis, Missouri
- John Theurer Cancer Center at Hackensack University Medical Center โ Hackensack, New Jersey
- Columbia University โ New York, New York
- Huntsman Cancer Institute, University of Utah โ Salt Lake City, Utah
- Hokkaido University Hospital โ Sapporo, Hokkaido
- Kyoto University Hospital โ Kyoto, Sakyo-ku
- National Cancer Center Hospital โ Chuo Ku, Tokyo
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in High Grade Glioma
- Circulating Tumor DNA Collection From Patients With High Grade Gliomas โ Toronto, Ontario
- A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma โ Aurora, Colorado
- PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma โ Aurora, Colorado
- Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors โ Aurora, Colorado
- MRI in High-Grade Glioma Patients Undergoing Chemoradiation โ Winston-Salem, North Carolina
Explore by condition: All High Grade Glioma clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.